A new Borderlands means a new burning question: which Vault Hunter class should you play? Since each vault hunter has three action skills, each with their own skill tree, there’s a pretty wide variety ...

Disney ordered Character.AI to stop creating chatbots that impersonate its iconic characters — from Mickey Mouse to Spider-Man to Darth Vader — raising concerns that the popular app’s bots have ...

Character.AI said Tuesday that it has removed Disney characters from its chatbot platform after the studio asked the developer to stop using its copyrighted characters without authorization. The ...

With roles reversed from previous shutdowns, Democrats could bear the brunt. On the first day of the 2013 government shutdown, Sen. Chuck Schumer, D-New York, had a message for Republicans who refused ...

This is read by an automated voice. Please report any issues or inconsistencies here. In the latest salvo between Hollywood and artificial intelligence companies, tech start-up Character.AI has ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Death in the leafy green Maryland suburbs! Beyond the Gates on Thursday killed off Doug McBride, the character originated by Jason Graham. Doug, who is married to Lauren Buglioli’s character Vanessa, ...

At the “Make with Notion” event on Thursday, the company announced the launch of its first AI agent. The agent will draw on all of a user’s notion pages and database as context, automatically ...

Feyd Rautha (Austin Butler) and Paul Atreides (Timothee Chalamet) face off in 'Dune: Part 2' Image via Warner Bros. Pictures Anybody who has seen the films of Denis Villeneuve knows that the man's ...

Talk of a spin-off of The Office has been happening ever since the show was first airing. (Remember the backdoor pilot for the spin-off about Dwight's family?) But now, it's actually happening! The ...

Amgen's bemarituzumab trial has taken a turn, with a final analysis showing weaker survival benefits than previously found in an earlier pre-specified interim analysis. In June, Amgen and China ...